Literature DB >> 33667713

Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms.

Takashi Kato1, Daisuke Murata1, Robert A Anders2, Hiromi Sesaki3, Miho Iijima4.   

Abstract

PTEN and p53 are highly mutated in many cancers. These two tumor suppressors have critical functions in the nucleus, such as DNA repair, cell cycle progression, and genome maintenance. However, the in vivo functional relationship of nuclear PTEN and p53 is unknown. Here, we analyzed the liver of mice in which nuclear PTEN and p53 are individually or simultaneously depleted. We found that nuclear PTEN loss greatly upregulates p53 expression upon oxidative stress, while the loss of p53 potentiates stress-induced accumulation of PTEN in the nucleus. Next, we examined oxidative stress-induced DNA damage in hepatocytes, and found that nuclear PTEN loss aggravated the damage while p53 loss did not. Notably, mice lacking nuclear PTEN had increased hepatocellular carcinoma under oxidative stress, while mice lacking p53 in hepatocytes had accelerated hepatocellular carcinoma and intrahepatic cholangiocarcinoma. The formation of cholangiocarcinoma appears to involve the transformation of hepatocytes into cholangiocarcinoma. Simultaneous loss of nuclear PTEN and p53 exacerbated both types of liver cancers. These data suggest that nuclear PTEN and p53 suppress liver cancers through distinct mechanisms.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; DNA damage; Hepatocellular carcinoma; Liver cancer; Nuclear PTEN; p53

Mesh:

Substances:

Year:  2021        PMID: 33667713      PMCID: PMC7995232          DOI: 10.1016/j.bbrc.2021.02.093

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Nuclear PTEN deficiency causes microcephaly with decreased neuronal soma size and increased seizure susceptibility.

Authors:  Atsushi Igarashi; Kie Itoh; Tatsuya Yamada; Yoshihiro Adachi; Takashi Kato; Daisuke Murata; Hiromi Sesaki; Miho Iijima
Journal:  J Biol Chem       Date:  2018-05-07       Impact factor: 5.157

2.  Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.

Authors:  C Bassi; J Ho; T Srikumar; R J O Dowling; C Gorrini; S J Miller; T W Mak; B G Neel; B Raught; V Stambolic
Journal:  Science       Date:  2013-07-26       Impact factor: 47.728

3.  The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.

Authors:  Takeki Uehara; Igor P Pogribny; Ivan Rusyn
Journal:  Curr Protoc Pharmacol       Date:  2014-09-02

4.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  Regulation of PTEN transcription by p53.

Authors:  V Stambolic; D MacPherson; D Sas; Y Lin; B Snow; Y Jang; S Benchimol; T W Mak
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

Review 6.  Wnt-β-catenin signalling in liver development, health and disease.

Authors:  Maria J Perugorria; Paula Olaizola; Ibone Labiano; Aitor Esparza-Baquer; Marco Marzioni; Jose J G Marin; Luis Bujanda; Jesus M Banales
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-02       Impact factor: 46.802

7.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

8.  PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells.

Authors:  Jacob A Eitel; Khadijeh Bijangi-Vishehsaraei; M Reza Saadatzadeh; Janak R Bhavsar; Michael P Murphy; Karen E Pollok; Lindsey D Mayo
Journal:  Cell Cycle       Date:  2009-03-21       Impact factor: 4.534

Review 9.  Tumour evolution in hepatocellular carcinoma.

Authors:  Amanda J Craig; Johann von Felden; Teresa Garcia-Lezana; Samantha Sarcognato; Augusto Villanueva
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-02       Impact factor: 46.802

10.  Genetic interactions between Pten and p53 in radiation-induced lymphoma development.

Authors:  Jian-Hua Mao; Di Wu; Jesus Perez-Losada; Hiroki Nagase; Reyno DelRosario; Allan Balmain
Journal:  Oncogene       Date:  2003-11-20       Impact factor: 9.867

View more
  4 in total

1.  Immunofluorescence Detection of Plasma Membranous PTEN in Cultured Cells.

Authors:  Takashi Kato
Journal:  J Histochem Cytochem       Date:  2022-02-24       Impact factor: 2.479

2.  Generating a new mouse model for nuclear PTEN deficiency by a single K13R mutation.

Authors:  Takashi Kato; Atsushi Igarashi; Hiromi Sesaki; Miho Iijima
Journal:  Genes Cells       Date:  2021-10-28       Impact factor: 1.891

3.  Nuclear PTEN deficiency and heterozygous PTEN loss have distinct impacts on brain and lymph node size.

Authors:  Atsushi Igarashi; Takashi Kato; Hiromi Sesaki; Miho Iijima
Journal:  Biochem Biophys Res Commun       Date:  2021-04-01       Impact factor: 3.322

4.  Sensitive Electrochemical Biosensor for Rapid Screening of Tumor Biomarker TP53 Gene Mutation Hotspot.

Authors:  Pengcheng Sun; Kai Niu; Haiying Du; Ruixin Li; Jiping Chen; Xianbo Lu
Journal:  Biosensors (Basel)       Date:  2022-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.